Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5

Authors: Xiang-hua Liu, Kai-hua Lu, Ke-ming Wang, Ming Sun, Er-bao Zhang, Jin-song Yang, Dan-dan Yin, Zhi-li Liu, Jing Zhou, Zhi-jun Liu, Wei De, Zhao-xia Wang

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of miR-196a in NSCLC and its clinical significance, as well as its biological role in tumor progression.

Methods

Expression of miR-196a was analyzed in 34 NSCLC tissues and five NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The effect of DNA methylation on miR-196a expression was investigated by 5-aza-2-deoxy-cytidine treatment and bisulfite sequencing. The effect of miR-196a on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Analysis of target protein expression was determined by western blotting. Luciferase reporter plasmids were constructed to confirm the action of miR-196a on downstream target genes, including HOXA5. Differences between the results were tested for significance using Student’s t-test (two-tailed).

Results

miR-196a was highly expressed both in NSCLC samples and cell lines compared with their corresponding normal counterparts, and the expression of miR-196a may be affected by DNA demethylation. Higher expression of miR-196a in NSCLC tissues was associated with a higher clinical stage, and also correlated with NSCLC lymph-node metastasis. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. Our analysis showed that miR-196a suppressed the expression of HOXA5 both at the mRNA and protein levels, and luciferase assays confirmed that miR-196a directly bound to the 3’untranslated region of HOXA5. Knockdown of HOXA5 expression in A549 cells using RNAi was shown to promote NSCLC cell proliferation, migration and invasion. Finally, we observed an inverse correlation between HOXA5 and miR-196a expression in NSCLC tissues.

Conclusions

Our findings indicate that miR-196a is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5. Thus, miR-196a may represent a potential therapeutic target for NSCLC intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60 (5): 277-300. 10.3322/caac.20073.CrossRefPubMed Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin. 2010, 60 (5): 277-300. 10.3322/caac.20073.CrossRefPubMed
2.
go back to reference Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I: Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007, 8 (9): 784-796. 10.1016/S1470-2045(07)70246-2.CrossRefPubMed Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I: Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007, 8 (9): 784-796. 10.1016/S1470-2045(07)70246-2.CrossRefPubMed
3.
go back to reference Farazi TA, Spitzer JI, Morozov P, Tuschl T: miRNAs in human cancer. J Pathol. 2011, 223 (2): 102-115. 10.1002/path.2806.CrossRefPubMed Farazi TA, Spitzer JI, Morozov P, Tuschl T: miRNAs in human cancer. J Pathol. 2011, 223 (2): 102-115. 10.1002/path.2806.CrossRefPubMed
4.
go back to reference Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297. 10.1016/S0092-8674(04)00045-5.CrossRefPubMed Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297. 10.1016/S0092-8674(04)00045-5.CrossRefPubMed
5.
go back to reference Chitwood DH, Timmermans MC: Small RNAs are on the move. Nature. 2010, 467 (7314): 415-419. 10.1038/nature09351.CrossRefPubMed Chitwood DH, Timmermans MC: Small RNAs are on the move. Nature. 2010, 467 (7314): 415-419. 10.1038/nature09351.CrossRefPubMed
6.
go back to reference Kosik KS: MicroRNAs and cellular phenotypy. Cell. 2010, 143 (1): 21-26. 10.1016/j.cell.2010.09.008.CrossRefPubMed Kosik KS: MicroRNAs and cellular phenotypy. Cell. 2010, 143 (1): 21-26. 10.1016/j.cell.2010.09.008.CrossRefPubMed
7.
go back to reference Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 2006, 6 (11): 857-866. 10.1038/nrc1997.CrossRefPubMed Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 2006, 6 (11): 857-866. 10.1038/nrc1997.CrossRefPubMed
8.
go back to reference Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, et al: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol. 2010, 12 (4): 390-399. 10.1038/ncb2039.CrossRefPubMed Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, et al: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol. 2010, 12 (4): 390-399. 10.1038/ncb2039.CrossRefPubMed
9.
go back to reference Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et al: Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest. 2009, 89 (5): 597-606. 10.1038/labinvest.2009.12.CrossRefPubMed Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et al: Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest. 2009, 89 (5): 597-606. 10.1038/labinvest.2009.12.CrossRefPubMed
10.
go back to reference Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis. 2010, 11 (1): 50-54. 10.1111/j.1751-2980.2009.00413.x.CrossRefPubMed Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis. 2010, 11 (1): 50-54. 10.1111/j.1751-2980.2009.00413.x.CrossRefPubMed
11.
go back to reference Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1. Mol Cancer Ther. 2012, 11 (4): 842-852. 10.1158/1535-7163.MCT-11-1015.CrossRefPubMed Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1. Mol Cancer Ther. 2012, 11 (4): 842-852. 10.1158/1535-7163.MCT-11-1015.CrossRefPubMed
12.
go back to reference Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB: MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 2011, 30 (23): 2644-2658. 10.1038/onc.2010.642.CrossRefPubMed Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB: MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 2011, 30 (23): 2644-2658. 10.1038/onc.2010.642.CrossRefPubMed
13.
go back to reference Braig S, Mueller DW, Rothhammer T, Bosserhoff A-K: MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cellular and Molecular Life Sciences. 2010, 67 (20): 3535-3548. 10.1007/s00018-010-0394-7.CrossRefPubMed Braig S, Mueller DW, Rothhammer T, Bosserhoff A-K: MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cellular and Molecular Life Sciences. 2010, 67 (20): 3535-3548. 10.1007/s00018-010-0394-7.CrossRefPubMed
14.
go back to reference Mueller DW, Bosserhoff AK: MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer. 2011, 129 (5): 1064-1074. 10.1002/ijc.25768.CrossRefPubMed Mueller DW, Bosserhoff AK: MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Int J Cancer. 2011, 129 (5): 1064-1074. 10.1002/ijc.25768.CrossRefPubMed
15.
go back to reference Guan Y, Mizoguchi M, Yoshimoto K, Hata N, Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, et al: MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance. Clinical Cancer Research. 2010, 16 (16): 4289-4297. 10.1158/1078-0432.CCR-10-0207.CrossRefPubMed Guan Y, Mizoguchi M, Yoshimoto K, Hata N, Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, et al: MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance. Clinical Cancer Research. 2010, 16 (16): 4289-4297. 10.1158/1078-0432.CCR-10-0207.CrossRefPubMed
16.
go back to reference Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al: MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene. 2008, 27 (52): 6667-6678. 10.1038/onc.2008.256.CrossRefPubMed Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al: MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene. 2008, 27 (52): 6667-6678. 10.1038/onc.2008.256.CrossRefPubMed
17.
go back to reference Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M, Gockel I: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 2009, 15 (17): 2089-2096. 10.3748/wjg.15.2089.CrossRefPubMedPubMedCentral Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M, Gockel I: High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 2009, 15 (17): 2089-2096. 10.3748/wjg.15.2089.CrossRefPubMedPubMedCentral
18.
go back to reference Zhang SZ: Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Molecular Cancer Therapeutics. 2005, 4 (10): 1577-1584. 10.1158/1535-7163.MCT-05-0106.CrossRefPubMed Zhang SZ: Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Molecular Cancer Therapeutics. 2005, 4 (10): 1577-1584. 10.1158/1535-7163.MCT-05-0106.CrossRefPubMed
19.
go back to reference Abramovich C, Humphries RK: Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol. 2005, 12 (3): 210-216. 10.1097/01.moh.0000160737.52349.aa.CrossRefPubMed Abramovich C, Humphries RK: Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol. 2005, 12 (3): 210-216. 10.1097/01.moh.0000160737.52349.aa.CrossRefPubMed
20.
go back to reference Iimura T, Pourquie O: Hox genes in time and space during vertebrate body formation. Dev Growth Differ. 2007, 49 (4): 265-275. 10.1111/j.1440-169X.2007.00928.x.CrossRefPubMed Iimura T, Pourquie O: Hox genes in time and space during vertebrate body formation. Dev Growth Differ. 2007, 49 (4): 265-275. 10.1111/j.1440-169X.2007.00928.x.CrossRefPubMed
21.
go back to reference Moens CB, Selleri L: Hox cofactors in vertebrate development. Dev Biol. 2006, 291 (2): 193-206. 10.1016/j.ydbio.2005.10.032.CrossRefPubMed Moens CB, Selleri L: Hox cofactors in vertebrate development. Dev Biol. 2006, 291 (2): 193-206. 10.1016/j.ydbio.2005.10.032.CrossRefPubMed
22.
go back to reference Magli MC, Barba P, Celetti A, De Vita G, Cillo C, Boncinelli E: Coordinate regulation of HOX genes in human hematopoietic cells. Proc Natl Acad Sci U S A. 1991, 88 (14): 6348-6352. 10.1073/pnas.88.14.6348.CrossRefPubMedPubMedCentral Magli MC, Barba P, Celetti A, De Vita G, Cillo C, Boncinelli E: Coordinate regulation of HOX genes in human hematopoietic cells. Proc Natl Acad Sci U S A. 1991, 88 (14): 6348-6352. 10.1073/pnas.88.14.6348.CrossRefPubMedPubMedCentral
23.
go back to reference Daniels TR, Neacato II, Rodriguez JA, Pandha HS, Morgan R, Penichet ML: Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia. 2010, 24 (9): 1555-1565. 10.1038/leu.2010.142.CrossRefPubMedPubMedCentral Daniels TR, Neacato II, Rodriguez JA, Pandha HS, Morgan R, Penichet ML: Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia. 2010, 24 (9): 1555-1565. 10.1038/leu.2010.142.CrossRefPubMedPubMedCentral
24.
go back to reference Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS: Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Res. 2007, 67 (12): 5806-5813. 10.1158/0008-5472.CAN-06-4231.CrossRefPubMed Morgan R, Pirard PM, Shears L, Sohal J, Pettengell R, Pandha HS: Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Res. 2007, 67 (12): 5806-5813. 10.1158/0008-5472.CAN-06-4231.CrossRefPubMed
25.
go back to reference Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS: Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer. 2010, 10: 89-10.1186/1471-2407-10-89.CrossRefPubMedPubMedCentral Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS: Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer. 2010, 10: 89-10.1186/1471-2407-10-89.CrossRefPubMedPubMedCentral
26.
go back to reference Plowright L, Harrington KJ, Pandha HS, Morgan R: HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer. 2009, 100 (3): 470-475. 10.1038/sj.bjc.6604857.CrossRefPubMedPubMedCentral Plowright L, Harrington KJ, Pandha HS, Morgan R: HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer. 2009, 100 (3): 470-475. 10.1038/sj.bjc.6604857.CrossRefPubMedPubMedCentral
27.
go back to reference Shears L, Plowright L, Harrington K, Pandha HS, Morgan R: Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol. 2008, 180 (5): 2196-2201. 10.1016/j.juro.2008.07.018.CrossRefPubMed Shears L, Plowright L, Harrington K, Pandha HS, Morgan R: Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P. J Urol. 2008, 180 (5): 2196-2201. 10.1016/j.juro.2008.07.018.CrossRefPubMed
28.
go back to reference Aulisa L, Forraz N, McGuckin C, Hartgerink JD: Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater. 2009, 5 (3): 842-853. 10.1016/j.actbio.2008.11.002.CrossRefPubMed Aulisa L, Forraz N, McGuckin C, Hartgerink JD: Inhibition of cancer cell proliferation by designed peptide amphiphiles. Acta Biomater. 2009, 5 (3): 842-853. 10.1016/j.actbio.2008.11.002.CrossRefPubMed
29.
go back to reference Mandeville I, Aubin J, LeBlanc M, Lalancette-Hebert M, Janelle MF, Tremblay GM, Jeannotte L: Impact of the loss of Hoxa5 function on lung alveogenesis. Am J Pathol. 2006, 169 (4): 1312-1327. 10.2353/ajpath.2006.051333.CrossRefPubMedPubMedCentral Mandeville I, Aubin J, LeBlanc M, Lalancette-Hebert M, Janelle MF, Tremblay GM, Jeannotte L: Impact of the loss of Hoxa5 function on lung alveogenesis. Am J Pathol. 2006, 169 (4): 1312-1327. 10.2353/ajpath.2006.051333.CrossRefPubMedPubMedCentral
30.
go back to reference Packer AI, Mailutha KG, Ambrozewicz LA, Wolgemuth DJ: Regulation of the Hoxa4 and Hoxa5 genes in the embryonic mouse lung by retinoic acid and TGFbeta1: implications for lung development and patterning. Dev Dyn. 2000, 217 (1): 62-74. 10.1002/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U.CrossRefPubMed Packer AI, Mailutha KG, Ambrozewicz LA, Wolgemuth DJ: Regulation of the Hoxa4 and Hoxa5 genes in the embryonic mouse lung by retinoic acid and TGFbeta1: implications for lung development and patterning. Dev Dyn. 2000, 217 (1): 62-74. 10.1002/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U.CrossRefPubMed
31.
go back to reference Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol. 2001, 158 (3): 955-966. 10.1016/S0002-9440(10)64042-4.CrossRefPubMedPubMedCentral Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF: HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol. 2001, 158 (3): 955-966. 10.1016/S0002-9440(10)64042-4.CrossRefPubMedPubMedCentral
32.
go back to reference Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 2000, 405 (6789): 974-978. 10.1038/35016125.CrossRefPubMed Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S: Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 2000, 405 (6789): 974-978. 10.1038/35016125.CrossRefPubMed
33.
go back to reference Gendronneau G, Lemieux M, Morneau M, Paradis J, Tetu B, Frenette N, Aubin J, Jeannotte L: Influence of Hoxa5 on p53 tumorigenic outcome in mice. Am J Pathol. 2010, 176 (2): 995-1005. 10.2353/ajpath.2010.090499.CrossRefPubMedPubMedCentral Gendronneau G, Lemieux M, Morneau M, Paradis J, Tetu B, Frenette N, Aubin J, Jeannotte L: Influence of Hoxa5 on p53 tumorigenic outcome in mice. Am J Pathol. 2010, 176 (2): 995-1005. 10.2353/ajpath.2010.090499.CrossRefPubMedPubMedCentral
34.
go back to reference Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S: HOXA5 regulates expression of the progesterone receptor. J Biol Chem. 2000, 275 (34): 26551-26555. 10.1074/jbc.C000324200.CrossRefPubMed Raman V, Tamori A, Vali M, Zeller K, Korz D, Sukumar S: HOXA5 regulates expression of the progesterone receptor. J Biol Chem. 2000, 275 (34): 26551-26555. 10.1074/jbc.C000324200.CrossRefPubMed
35.
go back to reference Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T, Lo PK, Zhang X, Sukumar S: HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 2007, 67 (17): 8007-8013. 10.1158/0008-5472.CAN-07-1405.CrossRefPubMed Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T, Lo PK, Zhang X, Sukumar S: HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 2007, 67 (17): 8007-8013. 10.1158/0008-5472.CAN-07-1405.CrossRefPubMed
Metadata
Title
MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5
Authors
Xiang-hua Liu
Kai-hua Lu
Ke-ming Wang
Ming Sun
Er-bao Zhang
Jin-song Yang
Dan-dan Yin
Zhi-li Liu
Jing Zhou
Zhi-jun Liu
Wei De
Zhao-xia Wang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-348

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine